Skip to main content

Table 1 Acute and late GI/GU toxicity (Maximum score)

From: Absorbable hydrogel spacer use in men undergoing prostate cancer radiotherapy: 12 month toxicity and proctoscopy results of a prospective multicenter phase II trial

Grade

GI toxicity scores (n %)

GU toxicity scores (n %)

 

Acute

Late

Acute

Late

0

23 (48.0%)

45 (95.7%)

10 (21.0%)

38 (80.9%)

1

19 (39.6%)1

2 (4.3%)2

20 (41.7%)3

8 (17.0%)4

2

6 (12.5%)

0 (0%)

17 (35.4%)5

1 (2.1%)

3

0 (0%)

0 (0%)

1 (2.1%)

0 (0%)

4

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Grade 1 or worse

25 (52.1%)

2 (4.3%)

38 (79.2%)

9 (19.1%)

Grade 2 or worse

6 (12.5%)

0 (0%)

18 (37.5%)

1 (2.1%)

  1. 11 subject was Grade 1 at Baseline, 21 subject was Grade 1 at Baseline, 33 subjects were Grade 1 at Baseline, 46 subjects were Grade 1 at Baseline, 53 subjects were Grade 1 at Baseline, 1 subject was Grade 2 at Baseline.